Cited by 186Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationGenomics and Chromatin Dynamics

The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis

Burda, P, Laslo, P, Stopka, T·2010·Leukemia

Abstract

Hematopoiesis is coordinated by a complex regulatory network of transcription factors and among them PU.1 (Spi1, Sfpi1) represents a key molecule. This review summarizes the indispensable requirement of PU.1 during hematopoietic cell fate decisions and how the function of PU.1 can be modulated by protein-protein interactions with additional factors. The mutual negative regulation between PU.1 and GATA-1 is detailed within the context of normal and leukemogenic hematopoiesis and the concept of 'differentiation therapy' to restore normal cellular differentiation of leukemic cells is discussed.

Integrity signals

Registry

Crossref · 10.1038/leu.2010.104

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Borzoi correctly predicts upregulation of SHTN1 expression owing to the creation of a CEBP binding motif.

    “Borzoi correctly predicts the upregulation of SHTN1 expression owing to the creation of a CEBP binding motif69–72 (see Supplementary Fig. 9a and Extended Data Fig. 6a,b for additional examples).”
  • PU.1 action is important or indispensable for sustained generation of all known hematopoietic precursors with lymphoid developmental potentials.

    “its action is also important or indispensable for sustained generation of all known hematopoietic precursors that have lymphoid developmental potentials (1–9).”

Cites

Flagged first, then by citations

1 of the 109 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Burda, P., Laslo, P., & Stopka, T.
Affiliations
  • Charles University (CZ)
  • St James's University Hospital (GB)
Corresponding author
Stopka, T
Venue
Leukemia
Published
2010-06-03
Volume
24
Issue
7
Pages
1249-1257
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2023603100
Cited by
184
References
109
Citations by year
2026: 10 · 2025: 19 · 2024: 14 · 2023: 18 · 2022: 25 · 2021: 19 · 2020: 10 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 1 · 2014: 7 · 2013: 8 · 2012: 7
FWCI
1.60
Type
journal article
Language
en
Open access
closed
Locations
  • Leukemia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • Ministerstvo Zdravotnictví Ceské Republiky
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
PU.1, GATA-1, transcription factors, hematopoiesis, leukemogenesis, protein-protein interaction, negative regulation, differentiation therapy
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Hematopoiesis, Humans, Leukemia, Proto-Oncogene Proteins, Trans-Activators, GATA Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review